Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Medical Internet Research|June 10, 2026
Ethical Governance of Large Language Models in Health Care: Trust, Responsibility, and Equity in Routine UseXiongwen Yang, Chuan Xu
Current Oncology Reports|May 9, 2014
The efficacy and safety of EGFR inhibitor monotherapy in non-small cell lung cancer: a systematic reviewXiongWen Yang, Ke Yang, KangYu Kuang
American Journal of Therapeutics|September 1, 2015
Risk of Hypertension With Sorafenib Use in Patients With Cancer: A Meta-Analysis From 20,494 PatientsXiongWen Yang, Xiong Pan, Xiaoshu Cheng, et al.
American Journal of Therapeutics|March 4, 2016
Risk of Gastrointestinal Events During Lapatinib Therapy: A Meta-Analysis From 12,402 Patients With CancerXiongWen Yang, Xiong Pan, Xiaoshu Cheng, et al.
Chinese Medicine|July 16, 2025
The emerging role of mitochondria in the pharmacological and toxicological effects of Tripterygium wilfordii Hook F: functions, targets and new therapeutic applicationsZhonghao Liu, Dan Li, Xiongwen Yang, et al.
American Journal of Therapeutics|August 18, 2015
Risk of Gastrointestinal Events During Vandetanib Therapy in Patients With Cancer: A Systematic Review and Meta-analysis of Clinical TrialsXiongWen Yang, Xiong Pan, Xiaoshu Cheng, et al.
International Journal of Clinical Pharmacy|July 16, 2015
Risk of treatment-related mortality with sorafenib in cancer patients: a meta-analysis of 20 randomly controlled trials : Risk of sorafenib-associated deathXiongwen Yang, Xiong Pan, Xiaoshu Cheng, et al.
Expert Opinion on Drug Safety|February 8, 2025
Adverse event profile of ocular injury associated with JAK inhibitors in patients with rheumatoid arthritis: a disproportionality analysisDan Li, Xiongwen Yang, Yueyan Li, et al.
Clinical Drug Investigation|February 20, 2024
Thromboembolic Events Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System (FAERS) DatabaseXiongwen Yang, Bo Yang, Dan Li, et al.
Cardiovascular Drugs and Therapy|December 4, 2024
Investigating Sodium-Glucose Cotransporter 2 Inhibitors Versus Other Glucose-Lowering Drugs on Ventricular Arrhythmias or Sudden Cardiac Death Using the US FDA Adverse Event Reporting SystemBo Xu, Tianqiao Zhang, Bo Kang, et al.
Pageof 3